Registry for the VERAFEYE imaging system during heart procedures
Part of Heart & circulation clinical trials.
This study is a registry that tracks the real-world use of a new imaging system called VERAFEYE during heart procedures for atrial fibrillation (irregular heartbeat) or left atrial appendage closure (stroke prevention). By participating, you help doctors learn how well this imaging tool works in everyday practice, and it may help guide your procedure more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older (or the legal age to consent in your state/country).
- You are scheduled for an atrial fibrillation ablation or a left atrial appendage closure procedure, and your doctor chooses to use the VERAFEYE system for imaging during your procedure.
- You can understand and sign a consent form, and you are willing to complete study assessments at an approved study center.
- You have not had a prior cardiac ablation or left atrial appendage closure procedure for your condition.
- You are not pregnant (or planning to become pregnant) during the study, and you have a negative pregnancy test within 7 days before the procedure.
- You are not currently enrolled in another treatment study (unless it's a mandatory government or observational registry).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging system (VERAFEYE) that helps doctors guide catheter ablation, a procedure to fix irregular heartbeats like atrial fibrillation. It aims to see if the system makes the procedure safer or more effective.
This study tests a new imaging catheter (VERAFEYE) to help doctors guide ablation procedures for atrial flutter or atrial fibrillation. It may lead to safer, more precise treatment of these heart rhythm problems.
This study is a registry that collects information from patients with atrial fibrillation who are having an ablation procedure. It aims to improve care and research by tracking outcomes. You may be able to join if you are scheduled for an ablation, and some participants may be asked to take part in additional optional sub-studies.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.